INHIBITION OF CSF-1 or CSF-1R FOR THE TREATMENT OF MINIMAL RESIDUAL DISEASE

Abstract

Embodiments of the disclosure include methods and compositions for treating minimal residual disease in an individual. In specific embodiments, the disclosure concerns methods of treating an individual with minimal residual disease with one or more inhibitors of CSF-1R and/or one or more …